0000000000408671

AUTHOR

Ulrik Birgersson

showing 2 related works from this author

Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial o…

2014

Summary Background Even though progress has been made, the detection of melanoma still poses a challenge. In light of this situation, the Nevisense electrical impedance spectroscopy (EIS) system (SciBase AB, Stockholm, Sweden) was designed and shown to have the potential to be used as an adjunct diagnostic tool for melanoma detection. Objectives To assess the effectiveness and safety of the Nevisense system in the distinction of benign lesions of the skin from melanoma with electrical impedance spectroscopy. Methods This multicentre, prospective, and blinded clinical study was conducted at five American and 17 European investigational sites. All eligible skin lesions in the study were exami…

AdultMalemedicine.medical_specialtySkin NeoplasmsAdolescentMedizinDermoscopyDermatologySensitivity and SpecificityBreslow ThicknessYoung AdultPositive predicative valueBiopsymedicineElectric ImpedancePhotographyHumansddc:610Prospective StudiesProspective cohort studyMelanomaEarly Detection of CancerAgedAged 80 and overmedicine.diagnostic_testbusiness.industryMelanomaOriginal ArticlesMiddle Agedmedicine.diseaseDermatologySurgeryClinical trialCarcinoma Basal CellDielectric SpectroscopyCutaneous melanomaCarcinoma Squamous CellFemalePatient SafetySkin cancerbusinessThe British journal of dermatology
researchProduct

Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma.

2012

Background Previous studies have shown statistically significant differences in electrical impedance between various cutaneous lesions. Electrical impedance spectroscopy (EIS) may therefore be able to aid clinicians in differentiating between benign and malignant skin lesions. Objectives The aim of the study was to develop a classification algorithm to distinguish between melanoma and benign lesions of the skin with a sensitivity of at least 98% and a specificity approximately 20 per cent higher than the diagnostic accuracy of dermatologists. Patients/Methods A total of 1300 lesions were collected in a multicentre, prospective, non-randomized clinical trial from 19 centres around Europe. Al…

AdultMalemedicine.medical_specialtySkin NeoplasmsAdolescentDermatologySensitivity and SpecificityYoung AdultmedicineAtypiaPrevalenceHumansDiagnosis Computer-AssistedElectrical impedance spectroscopyMelanomaAgedAged 80 and overbusiness.industryMelanomaReproducibility of ResultsMiddle Agedmedicine.diseaseDermatologyClinical trialEuropeDielectric SpectroscopyCutaneous melanomaDysplastic nevusFeasibility StudiesFemaleSkin cancerbusinessSkin lesionAlgorithmsSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
researchProduct